Gamida Cell Ltd (GMDA)

NASDAQ
5.340
-0.040(-0.74%)
After Hours
5.340
0.000(0.00%)
- Real-time Data
  • Volume:
    654,985
  • Bid/Ask:
    5.350/5.660
  • Day's Range:
    5.000 - 5.440

GMDA Overview

Prev. Close
5.34
Day's Range
5-5.44
Revenue
-
Open
5.44
52 wk Range
3.93-15
EPS
-2.12
Volume
654,985
Market Cap
316.13M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
329,541
P/E Ratio
-
Beta
-
1-Year Change
32.18%
Shares Outstanding
59,200,153
Next Earnings Date
Aug 10, 2021
What is your sentiment on Gamida Cell Ltd?
or
Market is currently closed. Voting is open during market hours.

Gamida Cell Ltd News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuySellSell
Technical IndicatorsStrong BuyStrong BuyBuyStrong SellStrong Sell
SummaryStrong BuyStrong BuyBuyStrong SellStrong Sell

Gamida Cell Ltd Company Profile

Gamida Cell Ltd Company Profile

Employees
111

Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious blood diseases. The company’s lead product candidate is omidubicel, a cell therapy that is in Phase III studies in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials in patients with severe aplastic anemia. It is also developing GDA-201, a natural killer cell-based cancer immunotherapy, which is in Phase I/II studies for the treatment of relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. The company was founded in 1998 and is headquartered in Jerusalem, Israel.

Read More
  • 75 usd soon
    0
    • Called it Edson :D
      0
      • Lol buy in dip
        0
    • $30 tomorrow
      0
      • exploded
        0
        • Soon it will explode
          0
          • Sleeping giant
            0
            Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
            Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.